Insider Trading History of Burroughs Amy L.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Burroughs Amy L. since 2021. This trader's CIK number is 1872564. At the time of last reporting, Burroughs Amy L. was the Chief Executive Officer of Terns Pharmaceuticals, Inc.. (stock ticker symbol TERN). Also see all insider trading activities at Terns Pharmaceuticals, Inc..

Note that in the past Burroughs Amy L. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Diamedica Therapeutics Inc. (DMAC) by Burroughs Amy L.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 DMAC 44,950 $141,592 0 $0 0 $0

Yearly summary of insider trading at Terns Pharmaceuticals, Inc. (TERN) by Burroughs Amy L.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 TERN 23,824 $92,831 0 $0 0 $0
2024 TERN 15,450 $110,467 0 $0 0 $0


Insider trading activities at 2 companies by Burroughs Amy L.:

1. Diamedica Therapeutics Inc. (DMAC)

2. Terns Pharmaceuticals, Inc. (TERN)

Table 1. Insider trading of Diamedica Therapeutics Inc. (DMAC) by Burroughs Amy L.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-08-16 DMAC Buy 44,950 3.15 141,592

Table 2. Insider trading of Terns Pharmaceuticals, Inc. (TERN) by Burroughs Amy L.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-25 TERN Buy 23,314 3.87 90,225
2024-11-30 TERN Buy 510 5.11 2,606
2024-12-05 TERN Buy 15,450 7.15 110,467

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Burroughs Amy L. (Chief Executive Officer of Terns Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.